aTyr Pharma to Participate in Panel at National Institutes of Health Rare Disease Day®
Panel to take place on Monday, February 28, 2022, at 2:55pm EST / 11:55am PSTSAN DIEGO, Feb. 23, 2022 (GLOBE...
Panel to take place on Monday, February 28, 2022, at 2:55pm EST / 11:55am PSTSAN DIEGO, Feb. 23, 2022 (GLOBE...
Collaboration to identify patient-selection biomarkers for Cyclerion’s investigational therapeutics in neurological and neuropsychiatric diseases associated with cognitive impairmentCAMBRIDGE, Mass. and...
Company’s partnership with Mighty Oak Medical for 3D printed, patient-specific technology continues advancing pediatric scoliosis treatmentWARSAW, Ind., Feb. 23, 2022...
-- INNA-051 is being developed to stimulate innate immunity and reduce the incidence and severity of respiratory viral infections, such...
PHILADELPHIA and VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...
BATON ROUGE, La., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health,...
Best corrected visual acuity and central subfield thickness were significantly improved at 36 monthsILUVIEN treatment resulted in a 70.5% reduction...
New Capabilities Allow 22nd Century to Accelerate Revenue Streams and Create Higher Value Commercial LinesBUFFALO, N.Y., Feb. 23, 2022 (GLOBE...
Highlights: Final three subjects in cohort three have been intravenously dosed; RECCE® 327 at 500mg indicating to be safe and...
Results Distinguish Deep TMS as More Effective in Subjects with Higher Anxiety Symptoms, Long Considered Less Responsive to Alternative TreatmentsBURLINGTON,...
MELBOURNE, Australia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader...
- Preclinical data demonstrates new RaniPill™ HC (High Capacity) delivered 500%-plus higher payloads than current RaniPill™ capsule - - Up...
State-of-the-art GMP manufacturing facility to support preclinical through commercial production of Intellia’s investigational therapiesNew facility in Waltham, Massachusetts expected to...
Interim Results expected mid-2022REHOVOT, Israel and WILMINGTON, Del., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a...
VANCOUVER, British Columbia,, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Simply Better Brands Corp. (the “Company” or “Simply Better Brands” or...
Staffed by a Highly Experienced Team of Licensed Hearing Professionals and Leading Salespeople from Competitor PlatformsAims to Enhance Customer Experience...
RESEARCH TRIANGLE PARK, N.C., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Agile Clinical Trial...
Vystar/Rotmans would have singular focus on furniture/bedding industry to be attractive reverse merger opportunityRxAir NewCo would include RxAir®, Vytex® and...
BANNOCKBURN, Ill., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH),...
Pivotal Trial to Assess the Potential of Aficamten to Improve Exercise Capacity, Heart Failure Symptoms and Functional ClassSOUTH SAN FRANCISCO,...